196 related articles for article (PubMed ID: 35568912)
1. Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library.
Li Q; Zhang F; Lu Y; Hu H; Wang J; Guo C; Deng Q; Liao C; Wu Q; Hu T; Chen Z; Lu J
J Nanobiotechnology; 2022 May; 20(1):231. PubMed ID: 35568912
[TBL] [Abstract][Full Text] [Related]
2. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region.
Deng Q; Guo Z; Hu H; Li Q; Zhang Y; Wang J; Liao C; Guo C; Li X; Chen Z; Lu J
Antiviral Res; 2022 Dec; 208():105446. PubMed ID: 36270543
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™.
Pedraza-Escalona M; Guzmán-Bringas O; Arrieta-Oliva HI; Gómez-Castellano K; Salinas-Trujano J; Torres-Flores J; Muñoz-Herrera JC; Camacho-Sandoval R; Contreras-Pineda P; Chacón-Salinas R; Pérez-Tapia SM; Almagro JC
BMC Infect Dis; 2021 Oct; 21(1):1121. PubMed ID: 34717584
[TBL] [Abstract][Full Text] [Related]
5. Selection and characterization of protective anti-chikungunya virus single domain antibodies.
Liu JL; Shriver-Lake LC; Zabetakis D; Anderson GP; Goldman ER
Mol Immunol; 2019 Jan; 105():190-197. PubMed ID: 30550981
[TBL] [Abstract][Full Text] [Related]
6. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein.
Chua CL; Chan YF; Sam IC
J Virol Methods; 2014 Jan; 195():126-33. PubMed ID: 24134938
[TBL] [Abstract][Full Text] [Related]
8. An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens.
Tsukahara N; Murakami A; Motohashi M; Nakayama H; Kondo Y; Ito Y; Azuma T; Kishimoto H
Int Immunol; 2022 Jul; 34(8):421-434. PubMed ID: 35689594
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic nanobody as citrinin mimotope from a naive alpaca heavy chain single domain antibody library.
Xu Y; Xiong L; Li Y; Xiong Y; Tu Z; Fu J; Chen B
Anal Bioanal Chem; 2015 Jul; 407(18):5333-41. PubMed ID: 25910884
[TBL] [Abstract][Full Text] [Related]
10. Specific determination of influenza H7N2 virus based on biotinylated single-domain antibody from a phage-displayed library.
Gong X; Zhu M; Li G; Lu X; Wan Y
Anal Biochem; 2016 May; 500():66-72. PubMed ID: 26450565
[TBL] [Abstract][Full Text] [Related]
11. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
Chua CL; Sam IC; Merits A; Chan YF
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
[TBL] [Abstract][Full Text] [Related]
12. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
[TBL] [Abstract][Full Text] [Related]
13. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
[TBL] [Abstract][Full Text] [Related]
14. Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications.
Yan J; Li G; Hu Y; Ou W; Wan Y
J Transl Med; 2014 Dec; 12():343. PubMed ID: 25496223
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus.
Basu R; Zhai L; Rosso B; Tumban E
Vaccine; 2020 Mar; 38(11):2542-2550. PubMed ID: 32044164
[TBL] [Abstract][Full Text] [Related]
16. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
Weber C; Büchner SM; Schnierle BS
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
[TBL] [Abstract][Full Text] [Related]
17. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
[TBL] [Abstract][Full Text] [Related]
18. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
19. Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their
Agarwal G; Gabrani R
Protein Pept Lett; 2021; 28(5):508-519. PubMed ID: 33121397
[TBL] [Abstract][Full Text] [Related]
20. Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.
Hultberg A; Temperton NJ; Rosseels V; Koenders M; Gonzalez-Pajuelo M; Schepens B; Ibañez LI; Vanlandschoot P; Schillemans J; Saunders M; Weiss RA; Saelens X; Melero JA; Verrips CT; Van Gucht S; de Haard HJ
PLoS One; 2011 Apr; 6(4):e17665. PubMed ID: 21483777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
